TriSalus Life Sciences
TLSI
TLSI
36 hedge funds and large institutions have $16.9M invested in TriSalus Life Sciences in 2025 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.97% more ownership
Funds ownership: 8.09% → 10.06% (+2%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
36
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.49M | |
| 2 | +$292K | |
| 3 | +$187K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$147K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$84.4K |
Top Sellers
| 1 | -$2.14M | |
| 2 | -$54.4K | |
| 3 | -$18.1K | |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$5.17K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.78K |